17-beta-hydroxysteroid dehydrogenase deficiency medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 3: Line 3:
{{CMG}}; {{AE}} {{Abdulkerim}}
{{CMG}}; {{AE}} {{Abdulkerim}}
==Overview==
==Overview==
If the diagnosis of 17 beta hydroxysteroid dehydrogenase deficiency is made at birth, [[gender]] assignment should be discused, depending on the expected result of [[verilizating]] [[genitoplasty]].
*If the diagnosis of 17 beta hydroxysteroid dehydrogenase deficiency is made at birth, [[gender]] assignment should be discussed, depending on the expected result of [[virilization]] [[genioplasty]].
 
==Medical therapy==
==Medical therapy==
*If the diagnosis of 17 beta hydroxysteroid dehydrogenase deficiency is made at birth, [[gender]] assignment should be discused, depending on the expected result of [[verilizating]] [[genitoplasty]].  
*If the diagnosis of 17 beta hydroxysteroid dehydrogenase deficiency is made at birth, [[gender]] assignment should be discused, depending on the expected result of [[verilizating]] [[genitoplasty]].  

Revision as of 07:35, 7 October 2022

17-beta-hydroxysteroid dehydrogenase deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Molecular Genetic Studies

Genotyping

X Ray

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

17-beta-hydroxysteroid dehydrogenase deficiency medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on 17-beta-hydroxysteroid dehydrogenase deficiency medical therapy

CDC on 17-beta-hydroxysteroid dehydrogenase deficiency medical therapy

17-beta-hydroxysteroid dehydrogenase deficiency medical therapy in the news

Blogs on 17-beta-hydroxysteroid dehydrogenase deficiency medical therapy

Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency

Risk calculators and risk factors for 17-beta-hydroxysteroid dehydrogenase deficiency medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdulkerim Yassin, M.B.B.S[2]

Overview

  • If the diagnosis of 17 beta hydroxysteroid dehydrogenase deficiency is made at birth, gender assignment should be discussed, depending on the expected result of virilization genioplasty.

Medical therapy

  • If the diagnosis of 17 beta hydroxysteroid dehydrogenase deficiency is made at birth, gender assignment should be discused, depending on the expected result of verilizating genitoplasty.
  • Feminizing genitoplasty and gonadectomy must be performed, if female assignment is opted. [1]

References

  1. "Orphanet: 46,XY disorder of sex development due to 17 beta hydroxysteroid dehydrogenase 3 deficiency".

Template:WH Template:WS